Silverback Therapeutics, Inc. (NASDAQ:SBTX – Get Free Report) reached a new 52-week high during trading on Friday . The stock traded as high as $14.90 and last traded at $14.51, with a volume of 383063 shares changing hands. The stock had previously closed at $14.53.
Silverback Therapeutics Price Performance
The stock has a market cap of $523.20 million, a P/E ratio of -6.00 and a beta of 0.60. The company has a fifty day moving average price of $14.66 and a 200 day moving average price of $11.91.
About Silverback Therapeutics
Silverback Therapeutics, Inc, a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver.
Featured Stories
- Five stocks we like better than Silverback Therapeutics
- Most active stocks: Dollar volume vs share volume
- The Latest 13F Filings Are In: See Where Big Money Is Flowing
- Dividend Payout Ratio Calculator
- 3 Penny Stocks Ready to Break Out in 2025
- How to Calculate Return on Investment (ROI)
- FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential
Receive News & Ratings for Silverback Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silverback Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
